Health resource usage in peri-transplant patients during 12 weeks of therapy with sofosbuvir (SOF), with or without ribavirin (RBV) and an NS5A inhibitor
Journal article published in 2015 by
Suman Verma,
Graham R. Foster,
William Irving,
John McLauchlan,
Michelle C. Cheung,
Benjamin E. Hudson,
Ivana Carey,
Kosh Agarwal 
